Wedbush Issues Pessimistic Forecast for Xometry (NASDAQ:XMTR) Stock Price

Xometry (NASDAQ:XMTR) had its price objective decreased by investment analysts at Wedbush from $70.00 to $60.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Wedbush’s price target would suggest a potential upside of 32.57% from the company’s current price.

Several other brokerages have also issued reports on XMTR. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Xometry in a research note on Wednesday, January 21st. JPMorgan Chase & Co. boosted their target price on Xometry from $55.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Cantor Fitzgerald upped their target price on Xometry from $41.00 to $60.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. The Goldman Sachs Group lifted their price target on shares of Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Finally, Citigroup reaffirmed an “outperform” rating on shares of Xometry in a research note on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $62.00.

Xometry Stock Performance

Shares of XMTR opened at $45.26 on Wednesday. Xometry has a 12-month low of $18.59 and a 12-month high of $73.87. The company has a current ratio of 3.76, a quick ratio of 3.58 and a debt-to-equity ratio of 1.18. The company has a market cap of $2.32 billion, a PE ratio of -37.10 and a beta of 0.86. The stock has a 50-day moving average price of $61.06 and a 200-day moving average price of $56.04.

Xometry (NASDAQ:XMTR) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.04. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The firm had revenue of $192.40 million for the quarter, compared to analyst estimates of $183.37 million. During the same quarter in the prior year, the firm earned $0.06 EPS. The business’s revenue for the quarter was up 29.5% compared to the same quarter last year. As a group, equities analysts forecast that Xometry will post -0.66 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Randolph Altschuler sold 31,928 shares of the business’s stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $43.44, for a total transaction of $1,386,952.32. Following the transaction, the chief executive officer owned 372,377 shares in the company, valued at $16,176,056.88. The trade was a 7.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Sanjeev Singh Sahni sold 9,978 shares of the stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $43.45, for a total transaction of $433,544.10. Following the completion of the transaction, the president directly owned 113,022 shares of the company’s stock, valued at approximately $4,910,805.90. The trade was a 8.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 127,852 shares of company stock valued at $6,993,940 over the last quarter. 9.66% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Kemnay Advisory Services Inc. purchased a new position in shares of Xometry in the 4th quarter valued at approximately $28,000. Quantbot Technologies LP purchased a new position in Xometry during the third quarter valued at $30,000. Advisors Asset Management Inc. lifted its position in Xometry by 68.3% during the second quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company’s stock valued at $34,000 after buying an additional 412 shares during the period. Westend Capital Management LLC bought a new stake in shares of Xometry during the 3rd quarter valued at $41,000. Finally, GAMMA Investing LLC grew its position in shares of Xometry by 26.5% in the 4th quarter. GAMMA Investing LLC now owns 773 shares of the company’s stock worth $46,000 after buying an additional 162 shares during the period. Hedge funds and other institutional investors own 97.31% of the company’s stock.

More Xometry News

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: UBS raised its price target slightly (from $54 to $55) and kept a neutral rating, signaling modest analyst support for the company’s near‑term outlook. Benzinga: UBS raises PT to $55
• Neutral Sentiment: Xometry published its Q4 2025 earnings call transcript and a CEO succession plan; these releases increase transparency but contain mixed/complex takeaways that investors will parse for guidance and leadership continuity. Yahoo Finance: Xometry Announces CEO Succession Plan Yahoo Finance: Q4 2025 Earnings Transcript
• Negative Sentiment: Multiple senior insiders sold stock on Feb 26 (CEO Randolph Altschuler, CFO James Miln, President Sanjeev Singh Sahni, and director Subir Dutt). The combined sales are large and represent multi‑percentage reductions in their individual holdings, which can be viewed negatively by the market. SEC filings: CEO sale SEC filing CFO sale SEC filing President sale SEC filing Director sale SEC filing
• Negative Sentiment: Several brokerages trimmed price targets: Citigroup cut its target from $75 to $65 (still a buy), Royal Bank of Canada cut from $64 to $55 (sector perform), and Wedbush cut from $70 to $60 (outperform). These downgrades on targets reduce upside expectations and add near‑term pressure. AmericanBankingNews: Citigroup cuts PT to $65 AmericanBankingNews: RBC cuts PT to $55 AmericanBankingNews: Wedbush sets PT to $60

About Xometry

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.